---
id: '1V1jU357jEM--obZeUiuPciuLwYEo43BBhZ3csuMov2U'
title: 'Redirect to: CMS 145 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)'
date: '2023-03-18T18:14:29.395Z'
source: 'https://drive.google.com/open?id=1V1jU357jEM--obZeUiuPciuLwYEo43BBhZ3csuMov2U'
mimeType: 'text/x-markdown'
url: '../quality-measure-specifications-and-recommended-workflows/cms-145-coronary-artery-disease-cad-beta-blocker-therapy-prior-myocardial-infarction-mi-or-left-ventricular-systolic-dysfunction-lvef-less40.md'
redirectTo: '1V1jU357jEM--obZeUiuPciuLwYEo43BBhZ3csuMov2U'
autogenerated: true
wikigdrive: '9a3c47814c851f1e3ce25659ea66b7640ddaf209'
---
Renamed to: [CMS 145 - Coronary Artery Disease (CAD): Beta-Blocker Therapy-Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <40%)](../quality-measure-specifications-and-recommended-workflows/cms-145-coronary-artery-disease-cad-beta-blocker-therapy-prior-myocardial-infarction-mi-or-left-ventricular-systolic-dysfunction-lvef-less40.md)
